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Abstract
Pursuing the molecular mechanisms of the concentration dependent cytotoxic and hemolytic effects of the human antimicrobial peptide LL-37
on cells, we investigated the interactions of this peptide with lipids using different model membranes, together with fluorescence spectroscopy for
the Trp-containing mutant LL-37(F27W). Minimum concentrations inhibiting bacterial growth and lipid interactions assessed by dynamic light
scattering and monolayer penetration revealed the mutant to retain the characteristics of native LL-37. Although both LL-37 and the mutant
intercalated effectively into zwitterionic phosphatidylcholine membranes the presence of acidic phospholipids caused augmented membrane
binding. Interestingly, strongly attenuated intercalation of LL-37 into membranes containing both cholesterol and sphingomyelin (both at X=0.3)
was observed. Accordingly, the distinction between target and host cells by LL-37 is likely to derive from i) acidic phospholipids causing
enhanced association with the former cells as well as ii) from attenuated interactions with the outer surface of the plasma membrane of the peptide
secreting host, imposed by its high content of cholesterol and sphingomyelin. Our results further suggest that LL-37 may exert its antimicrobial
effects by compromising the membrane barrier properties of the target microbes by a mechanism involving cytotoxic oligomers, similarly to other
peptides forming amyloid-like fibers in the presence of acidic phospholipids.
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A variety of antimicrobial peptides (AMPs) constitute in the
human body its first line of defense against microorganisms,
including bacteria, fungi, and enveloped viruses [1–3]. These
peptides have recently gained increasing interest because of their
potential for treating infections by bacteria resistant to conven-
tional antibiotics. Cathelicidins constitute a group of structurally
diverse AMPs found only in mammals [4–7], and derived their
name because of the similarity of their conserved N-terminal
proregions to cathelin [8–10], a porcine leukocyte inhibitor
of cathepsin L [3]. So far the only known human cathelicidin is
LL-37 [11], which was identified as a putative AMP in a cDNA
clone isolated from a human bone marrow library [4]. The
mature LL-37 peptide (LLGDFFRKSKEKIGKEFKRIVQ-
RIKDFLRNLVPRTES) was first isolated from granulocytes
[12] and is also expressed in mast cells, neutrophils, as well as
epithelial tissues, including skin, salivary glands, lung, urogen-
ital and gastrointestinal tract. It is secreted into wounds, sweat,
and airway surface fluids and is considered to play an important
role against both local infections and systemic invasion of
pathogens at sites of inflammation and damaged skin [13]. LL-
37 is not as selective as some other α-helical, amphipathic
AMPs, with MICs ranging from 1 to 10 μM for a variety of
Gram-positive and Gram-negative bacteria, with eukaryotic
cytotoxicity in vitro observed at 13–25 μM [14–16]. The
antimicrobial activity of LL-37 has been confirmed also in vivo
[17]. Intriguingly, in addition to its antimicrobial activity and
stimulation of the innate immune system, LL-37 has been shown
to be involved also in reproduction [18] and differentiation [19].
Recent studies on LL-37 have been mainly focused on its
antimicrobial and cytotoxic activities and factors, which can
inhibit its latter activity, such as truncation [20], and the presence
of serum [21], or plasma [22]. LL-37 binds human plasma
apolipoprotein A-I, which may act as a scavenger for this peptide
[23]. It also associates with both plasma low density and very low
density lipoproteins [22]. LL-37 is the first amphipathic α-helical
AMP isolated from human, with 16 charged residues and a net
charge of +6 at neutral pH [24]. Recent studies have shown that
the amphipathic helix of LL-37 lies parallel to the membrane
surface [21]. Neville et al. [25] observed lipid headgroup
discrimination by LL-37. More specifically, LL-37 in low
concentrations penetrates parallel to the plane into dipalmitoyl-
phosphatiglycerol monolayers and resides in the phospholipid
headgroup region. However, dipalmitoyl-phosphocholine and
-phosphoethanolamine monolayers remained virtually unaf-
fected. Oren et al. using fluorescence spectroscopy [21] and
Henzler-Wildman et al. using solid state nuclear magnetic
resonance and differential scanning calorimetery (DSC) [26]
came to the conclusion that LL-37 forms “carpets” on the surface
of both zwitterionic PC and negatively charged vesicles contain-
ing phosphatidylserine. NMR andDSC experiments revealed that
LL-37 induces positive curvature strain but does not break
membrane into smaller fragments or micelles [26–28]. More
detailed understanding of the LL-37-lipid interactions, including
structural changes that occur within the phospholipid bilayer,
could aid the rational design of novel antibiotics.In the present study we characterized the interactions of
LL-37 with model biomembranes using Langmuir balance,
dynamic light scattering, and circular dichroism. In order to
employ fluorescence spectroscopy we constructed a mutant
LL-37(F27W) with Phe27 replaced by Trp.
2. Experimental
2.1. Materials and methods
Hepes, EDTA, acryl amide, and Congo red were from Sigma. 1-Stearoyl-2-
oleoyl-sn-glycero-3-phosphocholine (SOPC), 1-palmitoyl-2-oleoyl-sn-glycero-3-
phospho-rac-glycerol (POPG), 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoserine
(POPS), 1-palmitoyl-2-(6,7-dibromostearoyl)-sn-glycero-3-phosphocholine [(6,7)-
Br2-PC], 1-palmitoyl-2-(9,10-dibromostearoyl)-sn-glycero-3-phosphocholine
[(9,10)-Br2-PC], 1-palmitoyl-2-(11,12-dibromostearoyl)-sn-glycero-3-phospho-
choline [(11,12)-Br2-PC], 2-decanoyl-1-{O-[11-(4,4-difluoro-5,7-dimethyl-4-
bora-3a,4a-diaza-sindacene-3-ropionyl)amino]undecyl}-sn-glycero-3-phosphol-
choline (Bodipy-PC), sphingomyelin, and cholesterol were from Avanti Polar
Lipids (Alabaster, AL). 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanol amino
N-(5-dimethylaminonaphthalene-1-sulfonyl), triethylammonium salt (DPPDns) and
1-oleoyl-2-{6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl}-sn-glycero-3-
phosphocholine (NBD-PC) were fromMolecular Probes (Eugene, OR). The purity
of lipids was checked by thin-layer chromatography on silicic acid coated plates
(Merck, Darmstadt, Germany) developed with a chloroform/methanol/water
mixture (65:25:4, v/v/v). Examination of the plates after iodine staining, and when
appropriate, upon UV illumination revealed no impurities. The concentrations of
the lipids were determined gravimetrically with a high precision electrobalance
(Cahn, Cerritos, CA) and lipid stock solutions were made in chloroform. Concen-
trations of fluorescent lipids DPPDns and NBD-PC were determined spectro-
photometrically using their molar absorptivities of 21,000 (in CH3OH) and
19,000 M−1 cm−1 (in C2H5OH) at 463 and 465, respectively. Large unilamellar
vesicles (LUVs, with diameters between 111 and 117 nm) were prepared by
extrusion (for cholesterol/sphingomyelin mixtures at 50 °C) through a 100 nmpore
size (Millipore, Bedford, MA) filters essentially as described previously [29]. LL-
37 and its F27W mutant were synthesized by Synpep (Dublin, CA) and their
purities (N98%) verified by HPLC and mass spectrometry. All other chemicals
were of analytical grade and from standard sources. Unless otherwise indicated the
experiments were conducted using 5 mM Hepes, 0.1 mM ethylenediaminete-
traacetic acid (EDTA), pH 7.0 buffer.
2.2. Antimicrobial activity of LL-37 and LL-37(F27W)
Bacillus subtilis strain 168 and Staphylococcus aureus strain Newman were
used to determine minimal inhibitory concentrations (MIC) for LL-37 and LL-
37(F27W). B. subtilis was grown in Luria–Bertani (LB) and modified
Spizizen's minimal salts media (BFA, Anagnostopoulos and Spizizen, 1961),
and S. aureus in BHI medium in shake flasks at 37 °C with vigorous shaking up
to cell densities yielding OD600=1. Approximately 10
5 cells of these cultures
were used to inoculate 150 μl of growth media in honeycomb two plate wells for
the determination of MIC values by plate reader (Bioscreen C Microbiology,
Growth Curves Ltd, UK). The peptides were added to each well in two-fold
dilution series from 0.5 μM to 16 μM, with three separate measurements for
each peptide concentration. The MIC was the lowest concentration at which no
bacterial growth was detected.
2.3. Circular dichroic (CD) spectra
UV-CD spectra from 250 to 190 nm were recorded with a CD spectro-
photometer (Olis RSF 1000F, On-line Instrument Systems Inc., Bogart, GA)with
cuvette temperature maintained at 25 °C with a circulating water bath. A 1-mm
path length quartz cell was used with final concentrations of 20 μM and 3 mM of
peptide and liposomes, respectively, in buffer. Interference by circular differential
scattering by liposomes was eliminated by subtracting CD spectra for liposomes
from those recorded in the presence of peptide. Data are shown as mean residue
molar ellipticity (deg cm2 dmol−1) and represent the averages of seven scans. The
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(θ222) [30].
2.4. Monolayer penetration
Insertion of LL-37 and LL-37(F27W) into lipid monolayers residing on an air/
buffer interfacewasmeasured using aminiaturized Langmuir tensiometer (DeltaPi,
Kibron Inc., Helsinki, Finland) with magnetically stirred circular Teflon wells,
essentially as described previously [31]. The indicated lipids (approximately 1 mg/
ml, in chloroform) were spread onto the air/buffer interface. All measurements
were made in triplicate and performed at ambient temperature (∼+24 °C).
2.5. Dynamic light scattering and measurement of zeta potential
The impact of LL-37 and LL-37(F27W) on the apparent size distribution of
LUVs was determined by DLS using photon correlation spectroscopy at a
scattering angle of 173° (Zetasizer Nano ZS, Malvern Instruments Ltd., UK).
Lipid concentration was 20 μM with the indicated concentrations of peptide
added and DLS performed after a 30 min incubation at 25 °C. Hydrodynamic
diameters (dZ, nm) were calculated from the diffusion coefficient (D) using the
Stokes–Einstein equation
dZ ¼ kT=3pgD ð1Þ
where k is the Boltzmann constant, T the absolute temperature, and η the
viscosity of the solvent. Each data point represents the mean of three inde-
pendent measurements.
The zeta potential (ζ) of the liposomes was determined by laser Doppler
electrophoresis with the above instrument using dedicated disposable cells.
From the obtained electrophoretic mobility, the zeta potential was calculated
using the Smoluchowski equation
f ¼ 4pgu=e ð2Þ
where u is the electrophoretic mobility, η the viscosity of the solvent, and ε its
dielectric constant. The lipid concentration used was 250 μM, chosen so as to
obtain a high enough count rate at 25 °C. Each data point represents the mean of
three independent measurements with SD.
2.6. Microscopy of amyloid-like fibrils
Amyloid-like fiber formation was assessed by adding LL-37 or LL-37
(F27W) to the buffer containing SOPC, SOPC/POPG, or SOPC/POPS
(XPOPG=XPOPS=0.2) LUVs to yield final peptide and lipid concentrations of
3 μM and 120 μM, respectively. The samples were observed by bright field
microscopy. For polarized microscopy, the fibers were incubated for 30 min with
10 μM Congo red and their resulting birefringence was observed using crossed
polarizers in the excitation and emission paths. When indicated, trace amounts
(X=0.02) of the fluorescent lipid NBD-PC was additionally included in the
liposomes, and fibers were formed as described above, imaging their
fluorescence with the confocal microscope with excitation at 488 nm [32].
2.7. Interactions with supported planar bilayers (SPB)
Supported bilayers were prepared as described previously [33]. In brief,
appropriate amounts of lipid stock solutions were mixed in chloroform to obtain
the desired compositions, with the fluorescent lipid derivative Bodipy-PC
constituting X=0.005 of total lipid. The solvent was removed under a stream of
nitrogen and the lipid residue subsequently maintained under reduced pressure
for at least 1 h. The dry lipids were hydrated with buffer at RT and the resulting
dispersions extruded through a 50 nm pore size polycarbonate filter (Millipore,
Bedford, MA). Bilayers were formed by liposome fusion on glass cover slips in
the presence of calcium [33].
2.8. Fluorescence spectra and lifetime measurements
All fluorescence measurements were performed in one cm path length quartz
cuvettes. LUVs were added to a solution of LL-37(F27W) (3 μM finalconcentration in buffer) maintained at 25 °C in a total volume of 2 ml. After
equilibration for one h fluorescence spectra were measured with a Perkin Elmer
LS 50B spectrometer with both emission and excitation bandpasses set at 5 nm.
The tryptophan residue of LL-37(F27W) was excited at 280 nm and emission
spectra were recorded from 290 to 450 nm, averaging five scans. Spectra were
recorded as a function of lipid/peptide (L/P) molar ratio and corrected for the
contribution of light scattering measured in the presence of vesicles only. Blue
shifts were calculated as the differences in center of mass of the emission spectra.
S.D. in the blue shift was less than 0.5 nm. Fluorescence lifetimes were measured
and data analyzed essentially as discussed previously [34].
2.9. Quenching of Trp emission by acrylamide, dansyl, and
brominated phophatidylcholines
To reduce the absorbance by acrylamide, excitation of Trp at 295 nm instead
of 280 nm was used [35]. Aliquots of a 3.0 M solution of this water-soluble
collisional quencher were added to a solution of the peptide in the absence or
presence of liposomes at a peptide/lipid (P/L) molar ratio of 1:80. The values
were corrected for scattering, the latter derived from acrylamide titration of a
vesicle blank. The data were analyzed according to the Stern–Volmer equation
[36].
F0=F ¼ 1þ Ksv Q½  ¼ 1þ kqs0 Q½  ð3Þ
where F0 and F represent the fluorescence intensities in the absence and presence
of the quencher (Q), respectively, and Ksv is the Stern–Volmer quenching
constant. The latter reflects in this case the accessibility of Trp to acrylamide and
is defined as
Ksv ¼ kqs0 ð4Þ
where kq is the bimolecular quenching constant and τ0 is the lifetime of the
fluorophore in the absence of quencher. As acrylamide is neutral it has no
electrostatic interactions with the headgroups of the negatively charged
phospholipids. On the premise that acrylamide does not significantly partition
into the membrane bilayer [35], the value for Ksv can be considered to provide a
measure of the bimolecular rate constant for collisional quenching of the Trp
residue in contact to the aqueous phase. Accordingly,Ksv depends on the amount
of free peptide in solution as well as the fraction of the peptide residing in the
surface of the bilayer.
To utilize the resonance energy transfer in assessing the binding of LL-37
(F27W) to phospholipids a fluorescent lipid, DPPDns, (X=0.03)was incorporated
into the liposomes as an acceptor. Small aliquots of 1 mM liposome solution were
added to 3 μMLL-37(F27W) in a total volume of 2ml buffer maintained at 25 °C.
Trp was excited at 280 nm with excitation and emission bandpasses set at 7 nm.
Energy transfer efficiencies were calculated using the equation
E ¼ 1 F=F0ð Þ ð5Þ
whereF0 andF represent the fluorescence intensities at 350 nm in the absence and
presence of acceptor, respectively.
Collisional quenching of Trp by brominated phospholipids (Br2-PC) was
utilized to assess its localization in bilayers. The indicated LUVs were added to a
solution of LL-37 (F27W) to yield a final peptide concentration of 3 μM in
buffer. After 1 h at 25 °C, emission spectra were recorded, averaging five scans.
The differences in the quenching of Trp fluorescence by (6, 7)-, (9, 10)-, and
(11, 12)-Br2-PC were used to calculate the probability for location of W27 in
the membrane using both the parallax method [37] and distribution analysis
[38,39].3. Results
3.1. Antimicrobial activities of LL-37 and LL-37(F27W)
In order to use Trp fluorescence in assessing the interactions
of LL-37 with lipid membranes we constructed an LL-37
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residue was selected for substitution so as to introduce a
minimal perturbation to the physicochemical characteristics of
the peptide. In order to check the impact of this replacement we
first compared the antimicrobial efficiencies of LL-37(F27W)
and the native peptide. For B. subtilisMIC values of LL-37 and
LL-37(F27W) were 2 and 4 μM in LB-medium, respectively,
and one μM for both peptides in BFA-medium. In contrast
S. aureus is highly resistant to LL-37 and no effect on its
growth was detected up to 16 μM concentrations of either LL-
37 or LL-37(F27W). Accordingly, we conclude the antimicro-
bial activity of LL-37 to be insignificantly affected by this
substitution.
3.2. Secondary structure of LL-37 and LL-37(F27W)
LL-37 is in a random disordered state at micromolar concen-
trations in water yet undergoes a cooperative transition into an
α-helix upon increasing its concentration [20]. CD spectra of
LL-37(F27W) were recorded to check if the single amino acid
substitution altered the secondary structure of the peptide. The
characteristic double minima at 208 nm and 222 nm (Fig. 1) was
observed for LL-37(F27 W) in buffer, revealing α-helical sec-
ondary structure, as reported for the native peptide [20]. In the
presence of SOPC and SOPC/POPG (XPOPG=0.4) LUVs the
calculated helical content increased to 13 and 22%, respectively.
3.3. Penetration of LL-37 and LL-37(F27W) into lipidmonolayers
In keeping with their amino acid compositions both LL-37
and LL-37(F27W) were surface active and intercalated effec-
tively into lipid monolayers, as illustrated for an SOPC/POPG
film (XPOPG=0.2) at an initial pressure π0=24.5 mN/m (Fig. 2,
panels A and B). The extent of their penetration into the lipid
films was indistinguishable as demonstrated by the similar
values for Δπ. However, the kinetics of binding were differentFig. 1. Circular dichroic spectra of 5 μM LL-37(F27W) in buffer (+) and in the
presence of SOPC/POPG, XPOPG=0 (○), 0.4 (▼) LUVs. Final lipid
concentration was 3 mM, corresponding to P/L=1/600. The temperature was
maintained at 20 °C with a circulating water bath.and a slight decrease in π was observed for native LL-37
following the initial intercalation (Fig. 2, panel A), before
reaching a plateau. This decrement was not observed for LL-37
(F27W). Irrespective of their overall net positive charge (+6)
both LL-37 and LL-37(F27W) inserted equally effectively into
both zwitterionic (SOPC) as well as negatively charged SOPC/
POPG (XPOPG=0.2) and SOPC/POPS (XPOPS=0.2) monolayers.
The values of packing pressure πc abrogating the intercalation
of LL-37(F27W) into monolayer were 44 (neat SOPC), and
47 mN/m (XPOPG=0.2 and XPOPS=0.2). For LL-37 these values
were 44 (neat SOPC), 48 (XPOPG=0.2), and 41 mN/m
(XPOPS=0.2). Interestingly, while cholesterol (X=0.1 or 0.3)
and sphingomyelin (X=0.1 or 0.3) alone attenuated the
intercalation of both LL-37 and LL-37 (F27W) into the mono-
layers, least efficient insertion was evident for monolayers con-
taining both cholesterol and sphingomyelin (XChol=XSpm=0.3,
Fig. 2, panels E and F), with πc=26 and 25 mN/m for LL-37
(F27W) and LL-37, respectively. This value is well below the
equilibrium lateral pressure of approximately 30–35 mN/m
estimated for biomembranes [40,41].
3.4. Changes in apparent liposome size and zeta potential
induced by LL-37 and LL-37(F27W)
Binding of LL-37 and LL-37(F27W) to liposomes was also
assessed by dynamic light scattering. Apparent average hydro-
dynamic diameters dZ of 92, 91, 93, and 98 nm were measured for
SOPC, SOPC/POPG (XPOPG=0.2), SOPC/Chol (X=0.1), and
SOPC/Chol/Spm (XChol=XSpm=0.3) liposomes, respectively.
Upon addition of LL-37(F27W) to SOPC and SOPC/Chol
(XChol=0.1) liposomes increase in dZ was observed until P/L=
0.005 and P/L=0.010 (Fig. 3, panel D), respectively. Upon further
addition of the peptide dZ decreases and becomes constant above
P/L=0.010 and 0.0125 for SOPC and SOPC/Chol (XChol=0.1)
liposomes, respectively. Addition of LL-37 and LL-37(F27W) to
liposomes with XPOPG=0.2 caused a progressive decrease in dZ at
all P/L ratios (Fig. 3, panels C & D). In contrast, an increase in dZ
was evident for SOPC/Chol/Spm (XChol=XSpm=0.3) liposomes
until P/L=0.025 (Fig. 3, panels C & D).
The values for the zeta potential ζ of SOPC, SOPC/Chol
(XChol=0.1), SOPC/Chol/Spm (XChol=XSpm=0.3) and SOPC/
POPG (XPOPG=0.2) liposomes were −15, −17, −19 and −47
mV, respectively (Fig. 3, panels A and B). Both peptides in-
creased ζ for zwitterionic as well as anionic liposomes and
caused charge reversal for zwitterionic liposomes at P/L=0.01.
Upon further addition of peptide (P/LN0.006) the values for ζ
remained unaltered.
3.5. Formation of amyloid-like fibers
Microscopy experiments revealed that fibrous aggregates
developed upon adding LL-37 or LL-37(F27W) to SOPC/
POPG (XPOPG=0.2) liposomes (Fig. 4, panel A). There was no
specificity with respect to the acidic phospholipid headgroup
and similar fibers were observed for SOPC with XPOPS=0.2
(data not shown). Subsequent Congo red staining of these fibers
did yield the light green birefringence characteristic for amyloid
Fig. 2. Insertion of LL-37 and LL-37(F27W) into lipid monolayers. Increase in surface pressure is depicted as a function of time following the injection of LL-37 (panel A)
andLL-37(F27W) ( panel B) to yield a final concentration of 0.3μMunderneath a SOPC/POPG (XPOPG=0.2)monolayer at an initial surface pressures (π0) of approximately
24.3 mN/m. Increments in surface pressure (Δπ) as a function of the initial surface pressure (π0) for monolayers of SOPC (○) alone and with XPOPG=0.2 (▿),
XPOPS=0.2 (□), or with XChol=0.3 (Δ), XSpm=0.3 (■), orXChol=XSpm=0.3 (●) due to either 0.3 μMLL-37 ( panels C and E) or LL-37(F27W) ( panels D and F) injected
at T≈24 °C into the subphase.
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amount of NBD-PC was present in the liposomes (Fig. 4, panel
C), thus revealing that the fibers incorporate phospholipids, as
shown for fibers formed by the other cytotoxic or apoptotic
proteins that we have studied [32,42,43].3.6. Interactions with supported bilayers
Wild-type LL-37 caused significant perturbation of sup-
ported lipid bilayers (SLBs) containing acidic phospholipids
(Fig. 5). Within the first 10 min a progressive vesiculation was
Fig. 3. Zeta potential (ζ) for liposomes composed of SOPC with XPOPG=0 (○), 0.2 (▿), XChol=0.1 (■), and SOPC with XChol=XSpm=0.3 (●) at the indicated peptide/
lipid ratios for LL-37 (panel A) and LL-37(F27W) (panel B), respectively. The experiments were carried out at ambient temperature (approximately 24 °C) and each data
point represents the mean of triplicate measurements. Also shown are apparent liposome sizes represented as the Z-average diameters for SOPC with XPOPG=0 (○),
0.2 (▿), XChol=0.1 (■), and with XChol=XSpm=0.3 (●) at the indicated P/L ratios of LL-37 (panel C) and LL-37(F27W) (panel D).
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in diameter emerging from the SLB. Subsequently, some of
these vesicles detached from the surface. Longer incubation (for
hours) led to further increase in the size of these vesicles as well
as spreading of some of them on the SLB and formation of
multibilayer structures. Notably, although the nominal peptide
concentration in these experiments was low (0.4 μM) this
corresponds to L/P ratio of ∼2:1, when taking into account the
total amount of lipid in the chamber (420 pmol). Changes
induced by LL-37(F27 W) were indistinguishable from those
due to the wild type peptide (data not shown).
3.7. Lipid induced changes in the fluorescence of LL-37(F27W)
We then studied the lipid association of LL-37(F27W) using
Trp fluorescence. In aqueous solutions emission maximum λmax
for LL-37(F27W) was observed at 350 nm, characteristic of Trp
in a polar environment. The fluorescence of LL-37 (F27W) was
markedly altered upon the addition of liposomes with λmax
shifting to shorter wavelengths (≈340 nm) together with en-hanced emission I, typically for Trp accommodated in a hy-
drophobic environment and in keeping with W27 residing in the
hydrocarbon region of the lipid bilayer. However, for liposomes
with XChol=XSpm=0.3 a shift of only approx.=1.5 nm in λmax
was observed (data not shown).
Fluorescence of Trp of LL-37(F27W) as a function of L/P ratio
did yield conventional binding curves (Fig. 6, panel A), with
significant differences between the different liposome composi-
tions. Yet, regardless of their composition the values for Δλmax
measured in the presence of liposomes reached a plateau at L/
P≈40. For neat SOPC liposomes and at L/P b20 the value for
Δλmax was approx. 10 nm, increasing less steeply with L/P. The
blue shift saturated at L/P=40 and was maximally approximately
12 nm. In the presence of SOPC/POPG liposomes there was a
sharp increase inΔλmax to 13 nm at L/P b20. This effect wasmost
pronounced with XPOPG=0.4, with blue shifts of about 12.5, 13.0,
and 14.0 nm at XPOPG=0.1, 0.2, and 0.4, respectively. Identical
changes in Trp emission were seen for liposomes containing
POPS instead of POPG. Accordingly, binding of LL-37(F27W)
to liposomes is not specific to the headgroup of the acidic
Fig. 4. Panel A: Bright field microscopy image of a fiber formed by LL-37(F27W) after mixing with SOPC/POPG (XPOPG=0.2) liposomes at ambient temperature
(approximately 24 °C). The final concentrations of the phospholipid and peptide were 100 μM and 3 μM. Panel B: The fiber formed by LL-37(F27W) but after staining
with Congo red (final concentration of 10 μM). Panel C: Incorporation of the fluorescent phospholipid analogue NBD-PC into the fiber. The latter was formed as
described above except that a trace amount (X=0.02) of NBD-PC was additionally included in the SOPC/POPG liposomes.
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measurements. Cholesterol at XChol=0.1 slightly attenuated the
changes inΔλmax, including the level of plateau. Upon increasing
the content of cholesterol (XChol=0.3) and further including also
sphingomyelin (XChol=XSpm=0.3) reduced dramatically the shiftFig. 5. Time course of supported lipid bilayer perturbation bywild-type LL-37. Time af
in the chamber was 0.4 μM in 20 mM Hepes, 0.1 mM EDTA, pH 7.0. Lipid compos
Panels corresponding to 0–20 min show the same patch of the bilayer.in λmax. Accordingly, at L/P=40 blue shifts of 10.0, 8.0, and
1.5 nm were evident for SOPC vesicles with XChol=0.1, XChol=
XSpm=0.1, and XChol=XSpm=0.3, respectively, suggesting that for
the latter composition themembrane association and penetration of
LL-37(F27W) into the lipid bilayer were strongly attenuated.ter the addition of LL-37 is indicated in the panels. Nominal peptide concentration
ition of the bilayer was SOPC/POPG/Bodipy-PC, (XPOPG=0.2, XBodipy=0.005).
Table 1
Values for the apparent dissociation constant (Kd, μM) and the corresponding
chi2 (χ2) for the binding of LL-37(F27W) to the indicated liposomes and
calculated by fitting the data to the Langmuir isotherm
Liposomes Kd, μM χ
2
SOPC 23.8 0.11
XPOPG=0.1 0.51 0.07
XPOPG=0.2 0.40 0.05
XPOPS=0.2 0.28 0.27
XPOPG=0.4 0.12 0.04
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values of the shift in λmax as a result of membrane incorporation
yield the apparent equilibrium dissociation constant Kd for the
different lipid compositions (Table 1). Kd decreases for nega-
tively charged liposomes compared to zwitterionic membranes,
indicating a higher affinity of LL-37(F27W) towards former.
Partition coefficients for vesicles with XChol=XSpm=0.3 could
not be evaluated due to the flatness of the curve (Fig. 6, panel
A). We also studied the variation of I as a function of L/P ratio
(Fig. 6, panel B). A decrease in I of Trp was observed at L/P=5
for all the lipid compositions studied. At L/PN5 the values for I
increased, with the largest increment observed at L/P=60 with
further addition of LUVs having an insignificant effect. At L/
P=5 the decrease in I is most pronounced for the zwitterionic
SOPC liposomes. As the content of POPG increased, decrease
in I was evident at L/P=5 (Fig. 6, panel B) and after this molar
ratio a pronounced and progressive increase in I was seen.
Similar behavior was observed with liposomes containing
POPS (XPOPS=0.2). Minor effect was evident at XPOPG=0.4Fig. 6. Panel A: Blue shift in the Trp emission maxima in the presence of
liposomes composed of SOPC with XPOPG=0 (○), 0.1 (Δ), 0.2 (▿), 0.4 (▼),
XPOPS=0.2 (►), XChol=0.1 (■), SOPC with XChol=XSpm=0.1 (□) and SOPC
with XChol=XSpm=0.3 (●) as a function of lipid/peptide ratio. Panel B: Changes
in fluorescence intensity as a function of lipid/peptide ratio. Symbols are identical
to those in panel A. The final concentration of LL-37(F27W) in all experiments
was 3 μM in a total volume of 2 mL of 5 mM Hepes, 0.1 mM EDTA, pH=7.0.
The temperature was maintained at 25 °C with a circulating water bath.where I first decreased at L/P=5, followed by an increase. The
increment in I was much smaller compared to XPOPG=0.1, 0.2,
and XPOPS=0.2 for which a progressive enhancement of
intensity was seen at L/PN10. In the presence of liposomes
containing both cholesterol and sphingomyelin at X=0.3 the
fluorescence intensity decreased slightly at all L/P ratios, in
keeping with the small change in the τav (see below).
3.8. Time resolved Trp fluorescence
Not only the spectral features but also the fluorescence
lifetimes (τf) of Trp depend on its microenvironment [44].
Representative fluorescence intensity decays for LL-37(F27W)
in buffer and in the presence of SOPC/POPG (XPOPG=0.2) LUVs
with their biexponential fitting and the statistical parameters used
to check the quality of the fit are illustrated (Fig. 7, panels A & B
and C & D, respectively). The average fluorescence lifetimes
(τav) are plotted as a function of L/P ratio (Fig. 7, panel C). The
variation in τav parallels the changes in steady state emission
intensity I at all L/P ratios. In brief, τav decreased up to L/P=5
while above this ratio its values increased and leveled off at
approximately L/P=40. At L/P=5 the decrease in τav is
significant for SOPC liposomes, however, as XPOPG increases,
decrease in τav diminished (Fig. 7, panel E). Above L/P=5 a
progressive increment in τav was evident. Similar behavior was
seen for liposomes containing POPS (XPOPS=0.2). As observed
in steady state measurements, behavior with XPOPG=0.4 was
different and was in accordance with the changes in I.
Accordingly, τav first decreased at L/P=5 and then increased,
however, the increment in τav was much smaller compared to
XPOPG=0.1, 0.2, andXPOPS=0.2. In the presence of SOPCLUVs
τav=4.2 ns at L/P=40 whereas values of 5.4 and 6.0 ns were
observed with XPOPG=0.1, and 0.2, respectively, in keeping with
the augmented interaction of the peptide with negatively charged
lipids. The decrease in τav observed at L/P≤10 for neat SOPC
and SOPC containing acidic phospholipids is somewhat
unexpected since due to fast deactivation processes Trp lifetimes
are shorter in polar solvents [45]. The shortening of τav could be
caused by proximity of W27 and R23 when in a helical
conformation, the latter residue having pKa of 12.48, and thus
being positively charged at physiological pH, leading to cation–π
interaction [46,47]. At L/P≥20 values of τav in the presence of
liposomes were longer compared to values measured in buffer,
indicating Trp to reside in a hydrophobic region of the bilayer.
For liposomes containing cholesterol and sphingomyelin τav
decreased at all L/P ratios with τav=3.3 ns being measured for
Fig. 7. Time resolved fluorescence intensity decay for LL-37(F27W) in buffer (+) at 25 °C (Panel A) and its weighed residuals ( panel B). The concentration of LL-37
(F27W) was 3 μM in a total volume of 2 mL of 5 mM Hepes, 0.1 mM EDTA, pH=7.0. Excitation wavelength was 295 nm with emission monitored at 350 nm. For
comparison intensity decay recorded in the presence of SOPC/POPG (XPOPG=0.2) LUVs (L/P=100) with residuals are also illustrated ( panels C and D, respectively).
Panel E: Average fluorescence lifetimes (τav) of membrane bound LL-37(F27W) as a function of lipid/peptide ratio. The fluorescence lifetimes were calculated for
liposomes composed of SOPC with XPOPG=0 (○), 0.1 (Δ), 0.2 (▿), 0.4 (▼), XPOPS=0.2 (►), and SOPC with XChol=XSpm=0.3 (●).
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λmax (Fig. 6, panel A) and I (Fig. 6, panel B), and revealing the
fluorophore to be in a polar environment, in line with the
observations on this composition being effective in restricting the
penetration of the peptide into the bilayer.
3.9. Quenching of Trp by acrylamide and FRET measurements
To investigate the orientation of LL-37(F27W) in the mem-
brane and lipid specificity of the peptide/liposome interaction
we used acrylamide as a water-soluble collisional quencher ofTrp. Stern–Volmer plots for Trp fluorescence demonstrated a
concentration dependent decrease both in the absence and
presence of liposomes without other effects on the spectra (data
not shown). In buffer Stern–Volmer constant Ksv was 11.8 M
−1,
revealing a direct access of the quencher to Trp. However, the
values for Ksv decreased significantly in the presence of SOPC,
SOPC/POPG, SOPC/POPS, and SOPC/Chol LUVs (Table 2),
indicating that Trp become accommodated within the bilayer,
the minor differences in Ksv suggesting similar and poor acces-
sibility of acrylamide to Trp. Interestingly, as the molar concen-
tration of both cholesterol and sphingomyelin in liposomes was
Table 2
The values of the Stern–Volmer quenching constant Ksv and the bimolecular
quenching constant kq (×10
−9 M−1 s−1) for LL-37(F27W) at L/P=80 by
acrylamide in buffer and in the presence of liposomes with the indicated
compositions
Liposomes Ksv kq
Buffer 11.8±0.2 3.10
SOPC 1.6±0.1 0.47
XPOPG=0.1 1.6±0.1 0.38
XPOPG=0.2 1.8±0.1 0.51
XPOPS=0.2 1.7±0.1 0.51
XPOPG=0.4 1.7±0.1 0.52
XChol=0.1 1.7±0.1 0.51
XChol/Spm=0.1 2.7±0.1 1.40
XChol/Spm=0.3 8.3±0.1 2.70
Fig. 8. Panel A: Emission spectra for LL-37(F27W) in the buffer (a) and in 2.5
(b), 5.0 (c), 7.5 (d), 10 (e), and 15 μM (f ) of SOPC/POPG/DPPDns (XPOPG=0.2)
liposomes. Panel B: Emission spectra for LL-37(F27W) in buffer (a) and in
the presence of increasing concentrations of SOPC/Chol/Spm/DPPDns (XChol=
XSpm=0.3) liposomes as in panel A. Panel C: Energy transfer efficiency from
Trp to dansyl as a function of liposome concentration for SOPC (○), SOPC with
XPOPG=0.2 (▿), and SOPC with XChol =XSpm=0.3 (●). The excitation
wavelength was at 280 nm. The final concentration of LL-37(F27W) was
3 μM in a total volume of 2 mL of 5 mM Hepes, 0.1 mM EDTA, pH=7.0. The
temperature was maintained at 25 °C with a circulating water bath.
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as reflected in the increase of Ksv confirming these lipids at
XChol=XSpm=0.3 to be highly effective in reducing the mem-
brane intercalation of LL-37(F27W).
Lipid binding of LL-37(F27W) was further assessed by
resonance energy transfer (RET) from Trp to dansyl-labeled lipid
(DPPDns) incorporated into liposomes. RET is demonstrated by
the attenuated Trp emission recorded in the range of 290 to
450 nm in the presence of increasing concentrations of SOPC/
POPG/DPPDns (XPOPG=0.2, XDPPDns=0.03) liposomes (Fig. 8,
panel A) in keeping with augmented membrane binding of LL-37
(F27W) in the presence of the negatively charged lipid (Fig. 8,
panel C). In the presence of SOPC and SOPC/Chol/Spm/DPPDns
(XChol=XSpm=0.3, XDPPDns=0.03) vesicles FRET efficiency was
low (Fig. 8), as expected from the other experiments.
3.10. Quenching of W27 by Br2-phosphatidylcholines
Whereas W27 was quenched significantly in SOPC mem-
brane by all three brominated lipids, most efficient quencher was
(9, 10)-Br2-PC (Fig. 9). Similar quenching profiles were evident
for POPG containing liposomes, however, the overall quenching
efficiency was enhanced by the presence of the acidic phos-
pholipid. Least effective quenching by brominated lipids was
evident in the presence of liposomes containing both cholesterol
and sphingomyelin (at X=0.3), again suggesting that LL-37
(F27W) was associated only weakly to the membrane surface.
From the above data we calculated the penetration depth of Trp
in bilayers by the parallax method [37] as well as distribution
analysis [38,39] summarized in Table 3. These data confirm that
the partitioning of the peptide into LUVs was strongly reduced
by cholesterol and sphingomyelin and that the insertion of this
peptide into the membrane was shallow.
4. Discussion
The aim of this study was to investigate the impact of different
lipids on the interactions of LL-37 with monolayers, liposomes,
and SLBs employed as model biomembranes. To better mimic
the conditions prevailing in vivo unsaturated phospholipids were
employed. In order to enable the use of fluorescence spectro-
scopy we constructed a mutant LL-37 with Phe27 replaced byTrp, this substitution chosen so as to have a minimal effect on the
physicochemical characteristics of the peptide. The other three
phenylalanines are flanked by cationic residues, which could in
principle, quench the fluorescence of Trp.We also did not want to
Table 3
Penetration depth of Trp for the membrane bound LL-37(F27W) by distribution
analysis and the parallax method
Lipid composition Distance from the centre of the bilayer ZcF (Å)
Distribution analysis Parallax method
SOPC 9.65±0.9 10.68±1.3
XPOPG=0.2 9.56±1.2 10.20±1.5
XChol/Spm=0.3 10.0±1.5 10.98±1.9
aDepths were calculated from the fluorescence quenching obtained with samples
containing brominated phosphatidylcholines (X=0.3). Samples were excited at
280 nm and emission was collected at 335 nm at L/P=100.
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predictable impact of π–π interactions on Trp emission. Notably,
the toxicity of LL-37 is not distinguished by Gram staining.
Accordingly, at this stage we only tested the peptide against two
Gram positive bacteria, B. subtilis and S. aureus and could
confirm that both sensitivity and insensitivity to LL-37,
respectively, of these microbes remained uninfluenced by the
mutation W27F. Subsequent analysis of CD spectra further
showed that the F27Wmutant (Fig. 1) had essentially identicalα-
helical contents measured for native LL-37 both in the absence
and presence of phospholipids, the latter increasing α-helicity
[20]. Further characterization and comparison of the interaction
of LL-37 and W27 mutant with lipids using monolayers and
dynamic light scattering did reveal no significant differences,
thus validating the F27W mutant as a model for LL-37.
A characteristic feature of cationic AMP's is that their
association and insertion into bilayers is greatly augmented by
the presence of negatively charged lipids. The latter constitute a
major portion of the outer bacterial membranes and this preference
is thought to underlie the differentiation by these peptides between
the host and target cell membranes [21,26,43]. Our monolayer
penetration measurements revealed that both LL-37 and LL-37
(F27W) intercalate equally effectively into both zwitterionic and
negatively charged monolayers. Yet, DLS and fluorescence spec-
troscopy did reveal acidic phospholipids to promote the inter-
action of LL-37 with membranes. Major finding of the present
study is that for membranes containing both cholesterol and
sphingomyelin (at X=0.3) the membrane association of LL-37
and LL-37(F27W) is greatly reduced. This result was confirmed
by fluorescence spectroscopy studies on the F27W peptide.
Eukaryotic plasma membranes are highly asymmetric with
respect to the lipid composition of their outer and inner leaflets.
More specifically, glycerophospholipids such as phosphatidy-
lethanolamine and phosphatidylserine constitute a major fraction
of the inner leaflet whereas sterols (cholesterol in mammals) and
sphingolipids are enriched in the outer leaflet [48–50]. HighFig. 9. Depth-dependent quenching of Trp fluorescence by SOPC liposomes
containing brominated phosphatidylcholines (X=0.30) at a lipid/peptide molar
ratio of 60. The concentration of LL-37(F27W) was 3 μM in a total volume of
2 mL of 5 mM Hepes, 0.1 mM EDTA, pH=7.0. The temperature was
maintained at 25 °C with a circulating water bath. Each data point represents the
mean of triplicate measurements.levels of sphingolipids and cholesterol have pronounced effects
on the physical properties of lipid bilayers co-segregating into a
distinct thermodynamic phase [51], the so-called liquid ordered
(lo) phase, different from both the solid ordered (so) and liquid
disordered (ld) phases [52–54]. Saturation is prevalent in
sphingolipids, thus promoting the formation of the lo phase.
The rigid sterol ring augments gauche→trans isomerization of
the lipid acyl chains and thus increases bilayer thickness, yet with
little effect on the lateral diffusion of lipids in the plane of the
bilayer. Cholesterol decreases the in-plane elasticity of PC and
sphingomyelinmonolayers [55] evident as high values for surface
compression modulus. Consistent with our observations choles-
terol at low mole fractions causes only a slight or no decrease in
in-plane elasticity. However, XChol≥0.2 results in an abrupt
reduction in the in-plane elasticity, in accordance with proximity
to a critical point in the phase diagram [54,56] with conversion to
lo phase and thickening of the membrane. The lo phase could be
crucial in reducing the membrane association of LL-37 and thus
protecting the hostmembranes from its membrane permeabilizing
action, essential for the antimicrobial activity of this peptide.
Oren et al. used N-terminal fluorescently labeled LL-37 and
FRET and concluded this peptide to oligomerize in the surface of
phosphatidylcholine vesicles [21]. However, their FRET studies
suggested that in the presence of negatively charged membranes
LL-37 is monomeric. This may contradict our current findings
showing the formation of amyloid-like fibrils by LL-37(F27W) to
be induced by acidic phospholipids (Fig. 4). Yet, this difference
could also result from the different peptide/lipid molar ratio used
in these studies. In this context it could be relevant to note that
because of poorly understood reasons FRET appears to be
suppressed in “amyloid-like” fibrils [57]. We have recently
reported on the formation of supramolecular protein-lipid fibers
by several cytotoxic proteins and peptides, including someAMPs
[29,32,42,43]. These fibers are macroscopic, with diameters of
tens of microns, and yield upon staining with Congo red a light
green birefringence, characteristic for amyloid. However, inspite
of this staining by Congo red, to emphasize the fact that the fibers
formedmay not necessarily consist of extensiveβ-sheet structure,
we have called these fibers “amyloid-like” [32]. As demonstrated
by us for cytochrome c, the fibers may consist of protein trapped
in different secondary structures, ranging from native-like con-
formation to extensive β-sheet [58]. Similarly to the other
proteins and peptides studied so far the formation of amyloid-like
fibrils by both LL-37 and LL-37(F27W) in the presence of
liposomes containing negatively charged phospholipids is likely
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of the peptides and the anionic phospholipids, exhibiting no
specificity with respect to the latter.
Fiber formation by LL-37 could be directly related to its
cytotoxicity, similarly to the toxicity of fibrils formed by the
paradigm of amyloid-forming peptides, Aβ, responsible for cell
death and loss of tissue function in Alzheimer's disease [59].
There seems to be now consensus on the “mature” amyloid being
inert and non-toxic to cells, while it is the early oligomeric states,
protofibrils, which are toxic [60]. We have suggested this same
mechanism to be responsible for both the pathological cytotoxi-
city of peptides such as Aβ, α-synuclein, and IAPP, as well as for
the physiological cytotoxicity of some apoptotic proteins as well
as antimicrobial peptides [31,42,43,61]. Mature amyloid fibers
consist of extensively aggregated β-sheet structures, with the
β-strands perpendicular to the fiber long axis [61], however, the
structure of the toxic oligomers is not known. Their formation is
preceded by aggregation, prompted by neutralization of their net
cationic charge by acidic lipids [31]. We have suggested the
“leaky slit” arrangement of the oligomers in membranes to fulfill
the minimal requirement for the permeabilization of the target cell
membrane [43]. Accordingly, the toxicity of this structure would
not require any particular secondary structure, just the formation
of a membrane inserted amphipathic oligomer with both
hydrophobic and hydrophilic facets [43,52].
Induction of positive curvature strain into bilayers has been
shown to be important for membrane disruption by cationic α-
helical AMPs, as demonstrated for magainin 2 [1], temporins [33],
and MSI-78 [62]. LL-37 disrupts the acyl chain packing and
cooperativity of DMPC (zwitterionic) and DMPC/DMPG
(anionic) bilayers and inserts into the hydrophilic/hydrophobic
interface of the bilayer with the hydrophobic face of LL-37 helix
extending approximately 5–6 Å from the surface into the
hydrophobic acyl chain region of the bilayer [26]. The decreased
access of the aqueous quencher acrylamide to Trp upon interaction
of LL-37(F27W) with lipid vesicles should be accompanied by an
increased accessibility to quenchers present in the hydrocarbon
phase of the bilayers. Quenching with brominated lipids indicate
that W27 resides at a distance of 9.65 to 9.56 Å from the center of
the bilayer in the presence of zwitterionic and negatively charged
membranes, locating in the shallow interfacial region near the
headgroups of the lipids, as previously observed for Trps of
several membrane embedded proteins and peptides [63,64].
Adsorption of the peptide on the membrane surface followed by
its insertion into the hydrophobic phase and the presence of Trp, in
the interfacial region supports the notion that the peptide first
forms a local “carpet” on the membrane surface. Once a critical
threshold concentration of the peptide is reached reorganization
would then occur, leading to membrane disruption.
Membrane association of LL-37(F27W) was enhanced with
net increasing negative surface charge density, irrespective of the
acidic lipid headgroup, thus causing an augmented increase in
Δλmax (Fig. 6, panel A). For SOPC the increase in Δλmax was
attenuated until L/P≤20 in keeping with the net charge of the
membrane determining its interactions with the peptide. However,
at L/P=100 change inΔλmax is comparable to that seen for acidic
liposomes, indicating that although electrostatic attractionincreases the affinity of the peptide to the membrane, also
hydrophobicity driven binding of the peptide to the membrane is
significant. The decrease in I at L/P≤10 could be attributed to LL-
37 existing as oligomers even at micromolar concentrations.
Accordingly, it could be in an aggregated state also upon bind-
ing to SOPC LUVs as well as on the surface of cholesterol/
sphingomyelin containing membranes. In the aggregated state the
Trp residues may be in close proximity to each other thus resulting
in self-quenching. Likewise, quenching could be caused by
proximity of Trp to positive charges of the peptide, as suggested
for nisin and temporin L [48]. Yet, also the charged headgroup of
POPG may interact directly with the π-orbitals of Trp [48].
Increase of ζ and dZ upon the addition of LL-37 to SOPC and
SOPC/cholesterol (XChol=0.1) liposomes is in accordance with a
gradual accumulation of the peptide onto the membrane. The
value for ζ becomes constant at P/L=0.006 suggesting that
peptide has saturated the membrane surface. However, at higher
peptide concentration dZ still decreases, perhaps indicating pene-
tration of peptide into the bilayer. In the presence of cholesterol
(XChol=0.1) higher surface contents of the peptide (P/L=0.01) are
needed for dZ to decrease, indicating diminished affinity of the
peptide to this membrane. The continuous increase in dZ at all P/L
ratios for liposomes containing XChol=XSpm=0.3 is likely to
indicate that peptide accommodates only on the surface of the
bilayer, in accordance with the least changes inΔλmax and effec-
tive quenching of Trp emission by acrylamide. Decrement in dZ in
the presence of acidic phospholipids at all P/L ratios byLL-37 and
LL-37(F27W) could be due to partial solubilization of liposomes
by the peptides. This behavior may be attributed to strong
electrostatic interactions at low peptide concentrations between
their positive charges and negatively charged lipid headgroup,
resulting in peptide aggregation and insertion into the bilayer.
Interestingly, a sharp increase in dZ was observed at P/L=0.1
(data not shown) in the presence of SOPC/POPG (XPOPG=0.2)
LUVs. This increase could be due to (i) vesicle aggregation due to
high peptide concentration, (ii) fragmentation of the bilayer via
carpet like mechanism, or (iii) formation of amyloid-like fibers.
The above processes could occur on negatively charged mem-
branes depending on the local peptide concentration, as is evident
from spectroscopic and microscopic observations. In DLS mea-
surements the size of the particles in aqueous solution is derived
from the translational diffusion coefficient of one particle,
reflected in the fluctuation of scattered light intensity. The
diffusion of fibrils should be slow. Accordingly, the size of the
fibrillar assembly would appear to be very large.
Supported lipid bilayers represent an interesting model
biomembrane to assess the impact of AMPs on the 2- and 3-D
organization of the resulting supramolecular assemblies [33].
Application of LL-37 and LL-37(F27W) at L/P≈2:1 on SLBs
containing negatively charged lipids caused the generation of
multilamellar and unilamellar vesicles, resulting in the disin-
tegration and rearrangement of the supported bilayer. This
suggests that at high L/P ratios peptide may accumulate in the
lipid bilayer surface, partially penetrating into the hydrophobic
region, accompanying the reduction of the surface charge due to
electrostatic peptide–lipid interactions. However, at lower L/P
the surface charge of the outer leaflet in bilayers is reduced or
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actions with other liposomes through charge interaction. The
reduction in surface charge may lead to a decrease in the ability of
peptides to attach to the lipid bilayer. As a result, the predominant
hydrophobic interaction between the peptide and lipids would
favor the penetration of LL-37 into the nonpolar acyl chain region,
perturbing the membrane and causing fusion, so as to lead to the
generation of unilamellar and multilamellar vesicles from the
supported bilayer. Interestingly, Hertog et al. [65] observed that
the association of LL-37 to the cell wall and plasma membrane of
Candida albicans, is accompanied by extensive disintegration of
the membrane into vesicle-like structures and leakage of vital
cellular components, including ATP. They also found LL-37 to
induce phase separation in the membrane, irrespective of its
efficiency of transmigration of membrane [65].
Our results with LL-37 (at 3 μM concentration, which is
within the MIC of this peptide) and model biomembranes using
different biophysical techniques reveal that although LL-37 is
effective in perturbing both zwitterionic (SOPC) as well as
mixed membranes containing the negatively charged POPG the
extent of membrane interactions of LL-37 are augmented in the
presence of latter phospholipid as evident from the larger shift in
λmax, higher Δπ, more efficient energy transfer, augmented
quenching by brominated phospholipids, higher α-helical
content, decrease in dZ, formation of amyloid-like fibers, and
generation of multilamellar and unilamellar vesicles from SLBs.
No differences in the binding of LL-37(F27W) to POPG and
POPS were evident thus corroborating the idea that electrostatic
interactions between the positively charged LL-37(F27W) and
negatively charged headgroups of POPG/POPS changes the way
peptide resides in the membrane and alters its aggregation state.
The penetration depth of the Trp residue is unlikely to depend on
the acidic lipid headgroup because the blue shift of fluorescence
emission was the same for both POPG and POPS containing
bilayers. The secondary structure of the peptide was also inde-
pendent of these lipid species (Fig. 1). Interestingly, membranes
containing both cholesterol and sphingomyelin (both at X=0.3)
were highly effective in attenuating the membrane binding of
LL-37. Accordingly, the distinction between target and host cells
by LL-37 is likely to derive from both enhanced association with
the former cells caused by acidic phospholipids as well as from
attenuated interactions with the outer surface of the plasma
membrane of the peptide secreting host, imposed by its high
content of cholesterol and sphingomyelin.
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